The global smart insulin pens market size is estimated at USD 183.25 million in 2025 and is predicted to reach around USD 676.01 million by 2034, accelerating at a CAGR of 15.65% from 2025 to 2034. The Europe smart insulin pens market size surpassed USD 76.97 million in 2025 and is expanding at a CAGR of 15.78% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Smart Insulin Pens Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Smart Insulin Pens Market, by Type
8.1.1. First Generation Pens
8.1.1.1. Market Revenue and Forecast
8.1.2. Second Generation Pens
8.1.2.1. Market Revenue and Forecast
9.1. Smart Insulin Pens Market, by Usability
9.1.1. Prefilled
9.1.1.1. Market Revenue and Forecast
9.1.2. Reusable
9.1.2.1. Market Revenue and Forecast
10.1. Smart Insulin Pens Market, by Product
10.1.1. Smart Insulin Pen
10.1.1.1. Market Revenue and Forecast
10.1.2. Adaptors for Conventional Pen
10.1.2.1. Market Revenue and Forecast
11.1. Smart Insulin Pens Market, by Connectivity Type
11.1.1. Bluetooth
11.1.1.1. Market Revenue and Forecast
11.1.2. USB
11.1.2.1. Market Revenue and Forecast
12.1. Smart Insulin Pens Market, by Indication
12.1.1. Type 1 Diabetes
12.1.1.1. Market Revenue and Forecast
12.1.2. Type 2 Diabetes
12.1.2.1. Market Revenue and Forecast
13.1. Smart Insulin Pens Market, by End User
13.1.1. Hospitals and Clinics
13.1.1.1. Market Revenue and Forecast
13.1.2. Ambulatory Surgical Centers
13.1.2.1. Market Revenue and Forecast
13.1.3. Home Care Settings
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type
14.1.2. Market Revenue and Forecast, by Usability
14.1.3. Market Revenue and Forecast, by Product
14.1.4. Market Revenue and Forecast, by Connectivity Type
14.1.5. Market Revenue and Forecast, by Indication
14.1.6. Market Revenue and Forecast, by End User
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type
14.1.7.2. Market Revenue and Forecast, by Usability
14.1.7.3. Market Revenue and Forecast, by Product
14.1.7.4. Market Revenue and Forecast, by Connectivity Type
14.1.8. Market Revenue and Forecast, by Indication
14.1.8.1. Market Revenue and Forecast, by End User
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type
14.1.9.2. Market Revenue and Forecast, by Usability
14.1.9.3. Market Revenue and Forecast, by Product
14.1.9.4. Market Revenue and Forecast, by Connectivity Type
14.1.10. Market Revenue and Forecast, by Indication
14.1.11. Market Revenue and Forecast, by End User
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type
14.2.2. Market Revenue and Forecast, by Usability
14.2.3. Market Revenue and Forecast, by Product
14.2.4. Market Revenue and Forecast, by Connectivity Type
14.2.5. Market Revenue and Forecast, by Indication
14.2.6. Market Revenue and Forecast, by End User
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type
14.2.8.2. Market Revenue and Forecast, by Usability
14.2.8.3. Market Revenue and Forecast, by Product
14.2.9. Market Revenue and Forecast, by Connectivity Type
14.2.10. Market Revenue and Forecast, by Indication
14.2.10.1. Market Revenue and Forecast, by End User
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type
14.2.11.2. Market Revenue and Forecast, by Usability
14.2.11.3. Market Revenue and Forecast, by Product
14.2.12. Market Revenue and Forecast, by Connectivity Type
14.2.13. Market Revenue and Forecast, by Indication
14.2.14. Market Revenue and Forecast, by End User
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type
14.2.15.2. Market Revenue and Forecast, by Usability
14.2.15.3. Market Revenue and Forecast, by Product
14.2.15.4. Market Revenue and Forecast, by Connectivity Type
14.2.16. Market Revenue and Forecast, by Indication
14.2.16.1. Market Revenue and Forecast, by End User
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type
14.2.17.2. Market Revenue and Forecast, by Usability
14.2.17.3. Market Revenue and Forecast, by Product
14.2.17.4. Market Revenue and Forecast, by Connectivity Type
14.2.18. Market Revenue and Forecast, by Indication
14.2.18.1. Market Revenue and Forecast, by End User
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type
14.3.2. Market Revenue and Forecast, by Usability
14.3.3. Market Revenue and Forecast, by Product
14.3.4. Market Revenue and Forecast, by Connectivity Type
14.3.5. Market Revenue and Forecast, by Indication
14.3.6. Market Revenue and Forecast, by End User
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type
14.3.7.2. Market Revenue and Forecast, by Usability
14.3.7.3. Market Revenue and Forecast, by Product
14.3.7.4. Market Revenue and Forecast, by Connectivity Type
14.3.8. Market Revenue and Forecast, by Indication
14.3.9. Market Revenue and Forecast, by End User
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type
14.3.10.2. Market Revenue and Forecast, by Usability
14.3.10.3. Market Revenue and Forecast, by Product
14.3.10.4. Market Revenue and Forecast, by Connectivity Type
14.3.11. Market Revenue and Forecast, by Indication
14.3.11.1. Market Revenue and Forecast, by End User
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type
14.3.12.2. Market Revenue and Forecast, by Usability
14.3.12.3. Market Revenue and Forecast, by Product
14.3.12.4. Market Revenue and Forecast, by Connectivity Type
14.3.12.5. Market Revenue and Forecast, by Indication
14.3.12.6. Market Revenue and Forecast, by End User
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type
14.3.13.2. Market Revenue and Forecast, by Usability
14.3.13.3. Market Revenue and Forecast, by Product
14.3.13.4. Market Revenue and Forecast, by Connectivity Type
14.3.13.5. Market Revenue and Forecast, by Indication
14.3.13.6. Market Revenue and Forecast, by End User
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type
14.4.2. Market Revenue and Forecast, by Usability
14.4.3. Market Revenue and Forecast, by Product
14.4.4. Market Revenue and Forecast, by Connectivity Type
14.4.5. Market Revenue and Forecast, by Indication
14.4.6. Market Revenue and Forecast, by End User
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type
14.4.7.2. Market Revenue and Forecast, by Usability
14.4.7.3. Market Revenue and Forecast, by Product
14.4.7.4. Market Revenue and Forecast, by Connectivity Type
14.4.8. Market Revenue and Forecast, by Indication
14.4.9. Market Revenue and Forecast, by End User
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type
14.4.10.2. Market Revenue and Forecast, by Usability
14.4.10.3. Market Revenue and Forecast, by Product
14.4.10.4. Market Revenue and Forecast, by Connectivity Type
14.4.11. Market Revenue and Forecast, by Indication
14.4.12. Market Revenue and Forecast, by End User
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type
14.4.13.2. Market Revenue and Forecast, by Usability
14.4.13.3. Market Revenue and Forecast, by Product
14.4.13.4. Market Revenue and Forecast, by Connectivity Type
14.4.13.5. Market Revenue and Forecast, by Indication
14.4.13.6. Market Revenue and Forecast, by End User
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type
14.4.14.2. Market Revenue and Forecast, by Usability
14.4.14.3. Market Revenue and Forecast, by Product
14.4.14.4. Market Revenue and Forecast, by Connectivity Type
14.4.14.5. Market Revenue and Forecast, by Indication
14.4.14.6. Market Revenue and Forecast, by End User
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type
14.5.2. Market Revenue and Forecast, by Usability
14.5.3. Market Revenue and Forecast, by Product
14.5.4. Market Revenue and Forecast, by Connectivity Type
14.5.5. Market Revenue and Forecast, by Indication
14.5.6. Market Revenue and Forecast, by End User
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type
14.5.7.2. Market Revenue and Forecast, by Usability
14.5.7.3. Market Revenue and Forecast, by Product
14.5.7.4. Market Revenue and Forecast, by Connectivity Type
14.5.8. Market Revenue and Forecast, by Indication
14.5.8.1. Market Revenue and Forecast, by End User
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type
14.5.9.2. Market Revenue and Forecast, by Usability
14.5.9.3. Market Revenue and Forecast, by Product
14.5.9.4. Market Revenue and Forecast, by Connectivity Type
14.5.9.5. Market Revenue and Forecast, by Indication
14.5.9.6. Market Revenue and Forecast, by End User
15.1. Emperra GmbH
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Bigfoot Biomedical
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Digital Medics Pty Ltd.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Jiangsu Deflu Medical Device Co.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Medtronic plc
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Eli Lilly and Company
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Novo Nordisk
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Pendiq
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Sanofi
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Berlin-Chemie
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client